The Crick is a new type of biomedical research institute. Our uncompromising commitment to excellence, our emphasis on multidisciplinary research, our focus on young and emerging talent, our novel ways of partnership working, and our plans to export our best people to other institutions are some of the factors that will set the Crick apart.
The Crick aspires to be one of the world's leading medical research institutes. At the heart of our philosophy is a commitment to the highest quality science. We believe that the necessary quality can only be delivered through a focus on the best and most imaginative scientists, which in turn requires a broad and flexible approach to our scientific programme.
The Francis Crick Institute is a unique partnership between six of the UK’s most successful scientific institutions. Its work is helping us to understand why disease develops and to find new ways to treat, diagnose and prevent illnesses such as cancer, heart disease, stroke, infections, and neurodegenerative diseases.
At the Crick we are passionate about our work and the benefits biomedical research can bring to people's health, the economy, and society. Our innovative and inclusive public engagement programme is designed to enlighten, inspire and entertain people of all ages and levels of understanding of science.
The Nobel Prize in Chemistry 2015 has been jointly awarded to Crick emeritus scientist Tomas Lindahl, with Paul Modrich and Aziz Sancar for 'mechanistic studies of DNA repair'.